Non-Euclidean geometry

FDA approves muscular dystrophy drug built on Children’s National research

Retrieved on: 
Vendredi, octobre 27, 2023

WASHINGTON, D.C., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food and Drug Administration’s approval Thursday of vamorolone, a steroidal-type, anti-inflammatory drug developed based on research performed at Children’s National Hospital.

Key Points: 
  • WASHINGTON, D.C., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food and Drug Administration’s approval Thursday of vamorolone, a steroidal-type, anti-inflammatory drug developed based on research performed at Children’s National Hospital.
  • Nearly two decades ago, ReveraGen leaders – President and CEO Eric Hoffman, Ph.D., and Vice President for Research Kanneboyina Nagaraju, D.V.M., Ph.D. – launched research efforts into the drug when they led the Center for Genetic Medicine Research at Children’s National.
  • DMD is the most common, severe and life-threatening form of muscular dystrophy.
  • “We cannot wait to see the tremendous effort behind vamorolone in the hands of patients and clinicians treating Duchenne muscular dystrophy,” Eskandanian said.

Raman spectroscopy market to grow by USD 287.28 million from 2022 to 2027 | The rising focus on drug discovery and development to boost market growth- Technavio

Retrieved on: 
Vendredi, octobre 13, 2023

The potential growth difference for the Raman spectroscopy market between 2022 and 2027 is USD 287.28 million.

Key Points: 
  • The potential growth difference for the Raman spectroscopy market between 2022 and 2027 is USD 287.28 million.
  • Buy the full report here
    The rising focus on drug discovery and development is the key factor driving market growth.
  • Thus, the increase in drug discovery and development will drive the demand for Raman spectroscopy, which will boost the growth of the market during the forecast period.
  • The global atomic spectroscopy market size is estimated to grow by USD 2,214.33 million at a CAGR of 7.02% between 2022 and 2027.

NotCo Levels-Up Your Coffee with Launch of NotMilk™ Barista

Retrieved on: 
Jeudi, octobre 12, 2023

NotCo, the global food tech company with a first-of-its-kind patented AI technology named Giuseppe, today unveiled the Canadian launch of its first plant-based beverage for coffee, NotMilk™ Barista.

Key Points: 
  • NotCo, the global food tech company with a first-of-its-kind patented AI technology named Giuseppe, today unveiled the Canadian launch of its first plant-based beverage for coffee, NotMilk™ Barista.
  • Made from a unique chickpea and oat blend, NotMilk™ Barista provides customers with a plant-based alternative that's creamier and frothier for coffees and teas.
  • "The feedback for NotMilk™ Barista has been off-the-charts positive with baristas raving about its creamy texture and frothing capability in hand-crafted coffee," said Andre Manuel, General Manager of NotCo Canada.
  • The fourth NotCo product to launch in Canada, NotMilk™ Barista can soon be found in select grocers across Canada, including Save on Foods and Longos.

Forum Health Named 2023 Hormone Therapy Provider by Healthcare Business Review

Retrieved on: 
Mardi, octobre 3, 2023

FLINT, Mich., Oct. 3, 2023 /PRNewswire/ -- Forum Health, LLC, leading national network of integrative and functional medicine providers, is setting itself apart with recognition from Healthcare Business Review for its personalized Bioidentical Hormone Therapy (BHRT) programs for women in menopause and men in andropause.

Key Points: 
  • The annual listing ranks the top companies at the forefront of providing hormone therapy services, positioning Forum Health as a leader in menopause care
    FLINT, Mich., Oct. 3, 2023 /PRNewswire/ -- Forum Health, LLC, leading national network of integrative and functional medicine providers, is setting itself apart with recognition from Healthcare Business Review for its personalized Bioidentical Hormone Therapy (BHRT) programs for women in menopause and men in andropause.
  • Tara Scott MD, FACOG, FAAFM, NCMP, Forum Health Akron: "Our integrative approach and expertise in the latest trends in hormone health, menopause and andropause is what sets us apart.
  • Forum Health's 360-degree approach offers:
    A variety of hormone delivery options - pellets, patches, creams and oral
    Learn more about Forum Health's BHRT approach.
  • Adam Puttkammer, Forum Health President: "This recognition establishes Forum Health as a leader in the field of BHRT and menopause treatment.

Just 3 Nobel Prizes cover all of science – how research is done today poses a challenge for these prestigious awards

Retrieved on: 
Vendredi, septembre 29, 2023

Today, and for the past 15 years, I’m a full-time historian of chemistry.

Key Points: 
  • Today, and for the past 15 years, I’m a full-time historian of chemistry.
  • Every October, when the announcements are made of that year’s Nobel laureates, I examine the results as a chemist.
  • And all too often, I share the same response as many of my fellow chemists: “Who are they?
  • I am not suggesting that these Nobel laureates are undeserving – quite the opposite.
  • What does this trend reveal about the Nobel Foundation and its award strategies in response to the growth of science?

A gradual evolution in the Nobel Prizes

    • Several years ago, chemist-historian-applied mathematician Guillermo Restrepo and I collaborated to study the relationship of scientific discipline to the Nobel Prize.
    • Each year, the Nobel Committee for chemistry studies the nominations and proposes the recipients of the Nobel Prize in chemistry to its parent organization, the Royal Swedish Academy of Sciences, which ultimately selects the Nobel laureates in chemistry (and physics).
    • We found a strong correlation between the disciplines of the members of the committee and the disciplines of the awardees themselves.
    • Restrepo and I concluded: As go the expertise, interests and the disciplines of the committee members, so go the disciplines honored by the Nobel Prizes in chemistry.

Not letting labels be limiting

    • And so, chemists do mind that the Nobel Prize in chemistry has morphed into the Nobel Prize in chemistry and the life sciences.
    • Since the Nobel Prizes were first awarded in 1901, the community of scientists and the number of scientific disciplines have grown tremendously.
    • Even chemistry as a discipline has grown dramatically, pushing outward its own scholarly boundaries, and chemistry’s achievements continue to be astounding.
    • And there just are not enough Nobel Prizes to go around to all the deserving.

Greentech Introduces Revolutionary Air Filter at IFMA World Workplace in Denver

Retrieved on: 
Jeudi, septembre 28, 2023

IFMA WORLD WORKPLACE – Greentech Environmental , a leading innovator in air filtration solutions, is proud to announce the launch of groundbreaking Greentech Filters+ with ODOGard®, delivering odor elimination at a molecular level within the filter.

Key Points: 
  • IFMA WORLD WORKPLACE – Greentech Environmental , a leading innovator in air filtration solutions, is proud to announce the launch of groundbreaking Greentech Filters+ with ODOGard®, delivering odor elimination at a molecular level within the filter.
  • View the full release here: https://www.businesswire.com/news/home/20230928817969/en/
    Combining two revolutionary technologies, this next-generation HVAC filter is a high-capacity MERV-rated filter with ultrafine filtration capabilities while achieving a lower pressure drop.
  • It’s a true mechanical filter with a low pressure drop, holding its MERV rating for the life of the filter, unlike electrostatic filters that lose their charge.
  • Nanofiber provides a more sustainable ecosystem for the environment by using 50% less synthetic material, so replacing a typical 24”x 24” x 2” filter with Greentech Filter saves the equivalent of 8.5 (16.9 oz.)

Galectin Therapeutics to Present Update on its Belapectin Liver Cirrhosis Program at the 20th Edition of Discovery on Target meeting, in Boston, September 25-28, 2023

Retrieved on: 
Mardi, septembre 26, 2023

The Company will present an update on its belapectin liver cirrhosis program during the Fibrosis and Inflammation session.

Key Points: 
  • The Company will present an update on its belapectin liver cirrhosis program during the Fibrosis and Inflammation session.
  • The presentation, titled “Targeting Activated Macrophages to Improve Liver Cirrhosis: The Discovery and Clinical Translation of Belapectin,” will take place Wednesday, September 27, at 2:25 PM EDT and will be delivered by Dr. Pol F. Boudes, M.D., Chief Medical Officer of Galectin Therapeutics.
  • Boudes commented: “The role of activated macrophages in the establishment and progression of liver cirrhosis is predominant1.
  • These cells, when activated, invade the liver, and produce galectin-3, a pro-inflammatory and pro-fibrotic molecule.

Digital Olfaction Startup Osmo Introduces Scent to the World of Artificial Intelligence in Breakthrough Science Paper

Retrieved on: 
Jeudi, août 31, 2023

Spun out of machine learning research done at Google Research, Osmo brings AI and olfactory science together to give computers a sense of smell.

Key Points: 
  • Spun out of machine learning research done at Google Research, Osmo brings AI and olfactory science together to give computers a sense of smell.
  • But with recent advances in AI, Osmo has been able to solve these long-standing challenges—marking a pivotal moment for engineering olfaction.
  • "AI has transformed so many processes in the chemical world, including drug discovery, but scent hasn't been tackled yet.
  • This reflects the underlying vision of Osmo—to catalyze the evolution of scent from ephemeral to enduring.

Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development Presents major research results of birociclib, the start product, at the international stage in ASCO

Retrieved on: 
Jeudi, juin 8, 2023

The excellent clinical results disclosed by Xuanzhu Biopharm at the ASCO annual meeting highlighted the development potential of birociclib.

Key Points: 
  • The excellent clinical results disclosed by Xuanzhu Biopharm at the ASCO annual meeting highlighted the development potential of birociclib.
  • We have over 40 medical aesthetics products and over 50 innovative drugs, many of which have already entered the harvesting stage.
  • Currently, Xuanzhu Biopharm has over 10 products approved to conduct clinical trials, and over 10 drug candidates in the preclinical development stage.
  • For more information about Sihuan Pharmaceutical, please visit the Company's website at https://www.sihuanpharm.com/
    Source: Sihuan Pharmaceutical Holdings Group Ltd.

IonQ Announces Second Quarter 2023 Financial Results

Retrieved on: 
Jeudi, août 10, 2023

IonQ (NYSE: IONQ), a leader in the quantum computing industry, today announced financial results for the quarter ended June 30, 2023.

Key Points: 
  • IonQ (NYSE: IONQ), a leader in the quantum computing industry, today announced financial results for the quarter ended June 30, 2023.
  • IonQ achieved $28.0 million in new bookings for the second quarter, and $32.2 million year-to-date.
  • For the third quarter of 2023, IonQ is expecting revenue of between $4.8 million and $5.2 million.
  • IonQ will host a conference call today at 4:30 p.m. Eastern time to review the Company’s financial results for the first quarter ended June 30, 2023 and to provide a business update.